19 February 2016
: Case report
Primary Breast Lymphoma in a Woman: A Case Report and Review of the Literature
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Gaby JabbourABEF, Gamela El-MabrokABEF, Hassan Al-ThaniABEF, Ayman El-MenyarBDEF, Ibrahim Al HijjiBDE, Sarbar NapakiBDEDOI: 10.12659/AJCR.896264
Am J Case Rep 2016; 17:97-103
Abstract
BACKGROUND: Primary breast lymphoma (PBL) is an unusual clinical entity accounting for 0.4–0.5% of all breast neoplasms. The usual presentation includes a painless palpable mass similar to that of breast carcinoma. Diffuse large B-cell lymphoma (DLBCL) is the most common identifiable type of PBL based on the histopathological examination.
CASE REPORT: We report an unusual case of a 43-year-old Indonesian woman who presented with a 7-month history of a painless mass in the left breast. A core needle biopsy revealed diffuse infiltration of large atypical lymphoid cells. The immuno-histochemical biomarkers confirmed the diagnosis of a DLBCL. A bone scan showed no evidence of bone metastasis. It was treated non-surgically, based on the decision of the breast multidisciplinary team (MDT). The patient was treated with 4 cycles of combination chemotherapy with R-CODOX/IVAC. A follow-up PET scan revealed non-significant mild F-18 fluorodeoxyglucose (FDG) uptake at the periphery of the residual left breast mass, indicating a radiologically favorable response.
CONCLUSIONS: Early and accurate diagnosis of PBL is crucial for selecting the appropriate MDT treatment strategies to avert potentially harmful surgical interventions.
Keywords: Breast Neoplasms - therapy, Lymphoma, Large B-Cell, Diffuse - therapy
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945910
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945852
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.944817
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946074
Most Viewed Current Articles
21 Jun 2024 : Case report
89,036
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,209
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,680
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,688
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030